| Trial Identifier: | D9480R00055 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT06185660 |
| Start Date: | February 2024 |
| Primary Completion Date: | March 2025 |
| Study Completion Date: | March 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Greece | Alexandroupolis, Greece, 68100 |
| Greece | Athens, Greece, 11527 |
| Greece | Athens, Greece, 12462 |
| Greece | Athens, Greece, 10676 |
| Greece | Athens, Greece, 15123 |
| Greece | Heraklion, Greece, 71500 |
| Greece | Larissa, Greece, 41110 |
| Greece | Patra, Greece, 26504 |
| Greece | Thessaloniki, Greece, 57010 |
| Greece | Thessaloniki, Greece, 54636 |